InvestorsHub Logo
Followers 283
Posts 1162
Boards Moderated 0
Alias Born 10/04/2020

Re: None

Monday, 10/25/2021 11:55:35 PM

Monday, October 25, 2021 11:55:35 PM

Post# of 118366
A Poster On Stockwits Today Asked "what's important About Nov 15th?"

Here's my reply to that person:

On Nov 15 the independent 3rd Party Valuation Assessment of RGBP by Biotech Research Group will be complete after which time Dr. Koos will have a clear understanding of what RGBP's actual Market Value is in a Buy Out situation. He will have a certified copy of his Company's valuation as "back up" going into formal negotiations for the sale of RGBP. Therefore he will know how to gage his offers to potential Big Pharma buyers.

What this strongly suggests is Koos is about to SELL RGBP to the highest bidder and IMO that will likely take place before the end of this year or within the 1st quarter of 2022!

He very likely is currently in preliminary discussions about a Buy Out and/or has informal pending offers on the table, but didn't want to proceed without an independent 3rd Party Valuation Assessment.

Now it's ALL making plenty of sense with him moving at warp speed over the past several months getting all his ducks in a row!

Buy Out straight ahead! If not, then having a qualified 3rd Party formal assessment of RGBP's valuation wouldn't make any sense, keeping in mind that Koos paid $25,000.00 up front to have this done!

Fact is, no one would place their house or business for sale on the market without having a clear understanding what its actual worth is via a formal assessment. This pertains more to businesses than the sale of real estate which is typically based on area comps but yet a formal appraisal can nevertheless be performed for a fee.

All feedback welcome.

Be well and prosper...